<DOC>
	<DOCNO>NCT00455273</DOCNO>
	<brief_summary>The project outline follow pilot investigation aim improve MRI parameter DCE-MRI optimize detection treatment response LABC . The primary objective define activity neoadjuvant chemotherapy patient biopsy proven operable breast cancer . Secondary objective include evaluate new MRI pulse sequence optimize DCE-MRI LABC response .</brief_summary>
	<brief_title>Dynamic Breast MRI Assessing Locally Advanced Breast Cancer</brief_title>
	<detailed_description>We conduct DCE-MRI prior completion neoadjuvant chemotherapy monitor response therapy . This do pilot study 5 patient enrol Sunnybrook Health Sciences Centre recruit project investigation . The patient scan research General Electric , 1.5 Tesla imaging system ( version 12 ) . We use specially design coil develop optimize breast MR imaging . These allow modest compression breast medial-lateral direction serf bring surface coil close breast possible immobilize breast achieve maximum coil couple image signal/noise . The dynamic data need cover entire breast , use fast T1 weight , dynamic breast MRI sequence [ 18 , 19 ] . This allow u collect dynamic MRI data cover tumour volume temporal resolution least 20 second per data set adequate spatial resolution ( ~1mm ) ensure adequate definition tumour boundary . The pulse sequence spoil gradient recall sequence ( SPGR ) image parameter TR/TE=8.2ms min-TE . The image collect field view 16-20 cm depend patient breast size . Imaging resolution approximately 1 mm in-plane 4-5 mm slice thickness . The specific sequence imaging study follow : 1 . A set localizer image position breast MRI system . 2 . A series 2D fast spin-echo T2 weight image cover breast . 3 . An SPGR imaging sequence use measure T1 distribution breast subsequent pharmacokinetic analysis describe Chen [ 20 ] . 4 . We administer intravenous Gd-DTPA ( 0.1 mmol/kg ) follow saline flush . 5 . Immediate prior Gd injection , start continuous application dynamic MRI sequence involve breast collect data 10 minute post injection Gd-DTPA . The image precede Gd injection approximately 2 minute provide adequate imaging data serve non contrast-enhanced baseline data . 3.2 - Data Analysis : These image use assess tumour follow : 1 . The simple measurement tumour size determine region enhancement see prior contrast enhancement versus see throughout 10 minute period post injection . 2 . We calculate T1 distribution throughout breast base multi-angle T1 weight SPGR sequence per Cheng [ 20 ] . 3 . This data use calculate [ Gd ] voxel image set . 4 . These used estimate Ktrans Ve two compartment tumour model [ 15 ] . 5 . We calculate parameter region interest define enhance tumour border . 6 . We estimate parameter pixel basis study tumour heterogeneity tumour characterize statistic parameter Ktrans Ve . The tumour volume measurement do Dr. P. Causer Department Medical Imaging Sunnybrook Health Sciences Centre . The analysis dynamic data do Dr. Plewes ' group Dr. A Martel Imaging Research conjunction Dr. Causer . The final result , measure change tumour volume neoadjuvant chemotherapy . In addition , information regard distribution Ktrans Ve region tumour variation therapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women locally Advanced Breast Cancer Contraindications MRI</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>DCE MRI</keyword>
</DOC>